Creative Biogene Released Cutomized CRISPR/Cas13 RNA Editing Services to Support Genomic Engineering

June 5, 2023

Crispr/cas9 platform, the mature division of Creative Biogene, focuses on developing professional products and services to help clients in gene research. With the excellent CRISPR/Cas9 platform and experienced scientists, Creative Biogene is capable of providing various custom gene-editing services for customers, including gene knockout, gene knockin and point mutation. Recently, Creative Biogene announced the release of its CRISPR/Cas13 RNA editing services to support genomic engineering research.


CRISPR/Cas9 Platform is experienced in providing a wide range of CRISPR system development services. Based on deep expertise in CRISPR systems and years of experience in CRISPR system applications, Creative Biogene has established a support platform for the potential application of CRISPR systems. The service expertise covers the latest Cas12 and Cas13, and it follows strict quality control standards and is fully optimized and verifies aspects of the project.


CRISPR/Cas9 Platform provides genomics and proteomics researchers with comprehensive CRISPR/Cas12a products and services to advance basic biology research, human disease research, and drug discovery. According to the gene ID provided by the customer, CRISPR/Cas9 Platform will screen at least three PAM (TTTN) sites, and use chemical modification methods to synthesize crRNA sequences to improve the stability of crRNA in target cells and further improve target editing performance.


CRISPR/Cas9 Platform provides a variety of vector designs, including crRNA only, crRNA-Cas12a, and also supports a variety of vectors, including non-viral and viral vectors (lentivirus, adenovirus, AVV), and has viral vectors capable of transfecting a variety of cells ability, including difficult-to-transfect cells, such as stem cells, primary cells, suspension cells, etc.


CRISPR/Cas9 Platform provides customized CRISPR/Cas13 related services to support a wide range of genome engineering applications. Research teams can apply the CRISPR/Cas13 system to RNA group editing, RNA imaging in live cells, gene therapy research for human diseases, and develop more potential applications for the Cas13 system. With the help of an experienced team of experts and a professional technical platform, CRISPR/Cas9 Platform provides customers with high-quality crRNA design and synthesis, CRISPR/Cas13 vector packaging, and dCas13 fusion protein production systems.


CRISPR/Cas9 Platform provides complete CRISPR-Cas9 services and products, covering from sgRNA design, to transfection and selection, to final product validation and sequencing. With years of experience and a stable platform, the team of scientists is an expert in the application of CRISPR-Cas9 systems. CRISPR/Cas9 Platform provides various CRISPR-Cas9 related services and products to assist in various stages of genome editing.


About Creative Biogene

Creative Biogene is a top-of-its-kind company that holds a leading position and is committed to accelerating the development of human science through biotechnology, offering innovative technologies, products, unique tools and services for research discoveries and product development. With more than 10 years of experience and in-house experts, Creative Biogene has become a well-recognized industry leader to support researchers worldwide.